OVN

Oventus Medical Limited

About OVN

Oventus Medical Limited (OVN) is an Australian medical device company with a proprietary oral appliance for the treatment of sleep apnoea and snoring. Oventus medical devices are manufactured using 3D printing technology. Oventus' Obstructive Sleep Apnea (OSA) treatment, called the O2Vent, has been demonstrated to be very effective and more desirable than other treatment options, offering hope for discreet, comfortable and effective relief to millions of people suffering from OSA.

Buy Australian shares starting with OVN. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Mr John Cox

Industry

Health Care Equipment & Supplies

Website

o2vent.com

Market Capitalisation

$5M

Price-earnings ratio

-0.33

Dividend yield

0.00%

High today

$0.02

Low today

$0.02

Open price

$0.02

52-week high

$0.05

52-week low

$0.02

Announcements

OVN FAQs

How much is one share of Oventus Medical Limited?

One share of Oventus Medical Limited is valued at $0.02.

What is the ticker symbol for Oventus Medical Limited?

The ticker symbol for Oventus Medical Limited is OVN.

How do I buy OVN shares in Australia?

To buy OVN stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in OVN

What is the 52-week high for Oventus Medical Limited stock?

The Oventus Medical Limited 52-week high stock price is $0.05.

What is the 52-week low for Oventus Medical Limited stock?

The Oventus Medical Limited 52-week low stock price is $0.02.

What is the market capitalisation of Oventus Medical Limited OVN?

As of 22/03/2023 Oventus Medical Limited has a market cap of $5M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.